(Q35135888)

6 August 2017

Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy (English)

1 reference

6 August 2017

D M Escolar

1

1 reference

6 August 2017

L P Hache

2

1 reference

6 August 2017

P R Clemens

3

1 reference

6 August 2017

A Cnaan

4

1 reference

6 August 2017

C M McDonald

5

1 reference

6 August 2017

V Viswanathan

6

1 reference

6 August 2017

A J Kornberg

7

1 reference

6 August 2017

T E Bertorini

8

1 reference

6 August 2017

Y Nevo

9

1 reference

6 August 2017

T Lotze

10

1 reference

6 August 2017

A Pestronk

11

1 reference

6 August 2017

M M Ryan

12

1 reference

6 August 2017

E Monasterio

13

1 reference

6 August 2017

J W Day

14

1 reference

6 August 2017

A Zimmerman

15

1 reference

6 August 2017

A Arrieta

16

1 reference

6 August 2017

E Henricson

17

1 reference

6 August 2017

J Mayhew

18

1 reference

6 August 2017

J Florence

19

1 reference

6 August 2017

F Hu

20

1 reference

6 August 2017

A M Connolly

21

1 reference

6 August 2017

language of work or name

English

0 references

publication date

13 July 2011

1 reference

6 August 2017

1 reference

6 August 2017

77

1 reference

6 August 2017

5

1 reference

6 August 2017

444-452

1 reference

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Glucocorticoid corticosteroids for Duchenne muscular dystrophy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Taking steps towards reducing osteoporosis in Duchenne muscular dystrophy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Validity of body mass index compared with other body-composition screening indexes for the assessment of body fatness in children and adolescents

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Decreased bone density in ambulatory patients with duchenne muscular dystrophy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Mutation analysis of the dystrophin gene in Southern French DMD or BMD families: from Southern blot to protein truncation test.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

A beneficial effect of oxandrolone in the treatment of Duchenne muscular dystrophy: a pilot study.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Steroids in Duchenne muscular dystrophy; pilot study of a new low-dosage schedule

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Profiles of neuromuscular diseases. Duchenne muscular dystrophy.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Population frequencies of inherited neuromuscular diseases—A world survey

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Intermittent prednisone therapy in Duchenne muscular dystrophy: a randomized controlled trial

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Bone mineral density and bone metabolism in Duchenne muscular dystrophy

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Bone mineral density and fractures in boys with Duchenne muscular dystrophy

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146308

Clinical trial in Duchenne dystrophy. I. The design of the protocol

27 September 2018

1 reference

12 December 2020

Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone

1 reference

12 December 2020

Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group

1 reference

12 December 2020

A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy

1 reference

12 December 2020

Short stature in Duchenne muscular dystrophy

1 reference

12 December 2020

Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months)

1 reference

12 December 2020

Deflazacort in Duchenne dystrophy: study of long-term effect

1 reference

12 December 2020

Assessment of whole body composition with dual energy x-ray absorptiometry in Duchenne muscular dystrophy: correlation of lean body mass with muscle function

1 reference

12 December 2020

Management of progressive muscular dystrophy in childhood

1 reference

12 December 2020

[Pain, osteopenia and body composition of 22 patients with Duchenne muscular dystrophy: a descriptive study]

1 reference

12 December 2020

10.1212/WNL.0B013E318227B164

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference